| Autor: |
Healy, Kelsey M., Ritter, Jacob, Barr, Emily, Churchill, Jessica L., Trasolini, Nicholas A., Waterman, Brian R., Reynolds, Alan W. |
| Zdroj: |
Current Reviews in Musculoskeletal Medicine; Dec2024, Vol. 17 Issue 12, p559-569, 11p |
| Abstrakt: |
Purpose of Review: The aim of this review is to aggregate currently available literature as it pertains to treating surgical shoulder pathology in patients with osteoporosis. Recent Findings: Emerging data surrounding perioperative use of anti-osteoporosis medications for patients undergoing shoulder surgery have not shown definitively favorable or unfavorable outcomes. Similar evaluations in animal studies have shown promising results as a biologic augment to tendon and bone healing, especially with newer, anabolic agents. Summary: The mainstay of bone health management remains pre-operative evaluation, using opportunistic radiographic and CT based validated measurements, along with optimization of risk factors. Surgical techniques continue to incorporate implants that perform well in osteopenic bone. Promising pre-clinical studies have identified anabolic anti-osteoporosis medications as viable biologic augments to shoulder surgery, which has not been borne out in any clinical studies at this time. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink